Hosted on MSN2mon
Neurogene stock plunges 36% on NGN-401 study updateThe patient, who had received a 3E15 vg dose of NGN-401, experienced systemic hyperinflammatory ... in the 1E15 vg cohort in Q4 as it updates the protocol to reflect the discontinuation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback